About the Institute for Translational Neuroscience
The Institute for Translational Neuroscience (ITN) represents a unique approach to identifying and developing new medications and novel therapeutics for drug and alcohol abuse, PTSD, stress, anxiety, impulsivity, and depression, and on understanding the neural mechanisms responsible for these disorders.
The Institue for Translational Neuroscience
The ITN includes investigators with track records conducting research in these areas and includes a team that provides support for regulatory approvals, data sharing, study design, and outreach to partners for ITN projects, facilitated through centralized ITN core support facilities. Over the past several years, the ITN team has worked on the development of psychedelic therapeutics for a range of psychiatric conditions, including MDMA for PTSD and psilocybin for demoralization and depression.
The ITN
The ITN includes investigators with track records conducting research in these areas and includes a team that provides support for regulatory approvals, data sharing, study design, and outreach to partners for ITN projects, facilitated through centralized ITN core support facilities. Over the past several years, the ITN team has worked on the development of psychedelic therapeutics for a range of psychiatric conditions including MDMA for PTSD and psilocybin for demoralization and depression.